The gastrointestinal safety and effect on disease activity of etoricoxib, a selective Cox-2 inhibitor in inflammatory bowel diseases

American Journal of Gastroenterology

Volumn 101, Issue 2, 2006, Pages 311-317

  El Miedany, Yasser ^a,c   Youssef, Sally ^a   Ahmed, Ihab ^b   El Gaafary, Maha ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Saudi German Hospital   (Saudi Arabia)

^c AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; ETORICOXIB; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENTERITIS; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC DISEASE; SCORING SYSTEM; TREATMENT WITHDRAWAL; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PYRIDINES; RHEUMATIC DISEASES; SEVERITY OF ILLNESS INDEX; SULFONES; TREATMENT OUTCOME;

EID: 33644900228     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00384.x     Document Type: Article

References (29)

1. O'Neill GP Ford-Hutchinson AW Expression of mRNA for cycloxygenase-1 and cycloxygenase-2 in human tissues FEBS Lett 1993 330 156 60
2. Flemstrom G Stimulation of HC03 - Transport in isolated proximal bull frog duodenum by prostaglandins Am J Physiol 1980 239 G198 G203
3. Miller TA Protective effects of prostaglandins against gastric mucosal damage: Current knowledge and proposed mechanisms Am J Physiol 1983 245 G601 23
4. Maier JAM Hla T Maciag H Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells J Biol Chem 1990 265 1085 8
5. Lee SH Soyoola E Chanmugam P et al Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide J Biol Chem 1992 267 25934 8
6. O'Banion MK Winn VD Young DA cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase Proc Natl Acad Sci U S A 1992 89 4888 92
7. Xie W Robertson DL Simmons DL Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal anti-inflammatory drugs Drug Dev Res 1992 25 249 65
8. Cohn SM Schloemann S Tessner T et al Crypt stem cell survival in mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooyxgenase-1 J Clin Invest 1997 99 1367 79
9. Eckman L Stenson WF Savidge TC et al Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria J Clin Invest 1997 100 296 309
10. Jung HC Eckman L Yang SK et al A distinct array of proinflammatory cytokines is expressed in human colonic epithelial cells in response to bacterial invasion J Clin Invest 1995 95 55 65
11. Evans JM McMahon AD Murray FE Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease Gut 1997 40 619 22
12. Felder JB Korelitz BI Rajapakse R Effects of nonsteroidal anti-inflammatory drugs on inflammatory bowel disease; a case-control study Am J Gastroenterol 2000 95 1949 54
13. Kaufmann HJ Taubin HL Nonsteroidal-anti-inflammatory drugs activate quiescent inflammatory bowel disease Ann Intern Med 1987 107 513 6
14. Rampton DS Sladen GE Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs Postgrad Med J 1981 57 667 297 9
15. Bonner GF Walczak M Kitchen L et al Tolerance of nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease Am J Gasterol 2000 95 1946 8
16. Dominitz JA Boyko EJ Association between analgesic use and inflammatory bowel disease flares: A retrospective cohort study Gastroenterology 2000 118 4 A3024
17. Hanauer SB Sandborn W Management of Crohn's disease in adults Am J Gastroenterol 2001 96 635 43 review
18. Munkholm P Langholz E Davidson M et al Disease activity courses in a regional cohort of Crohn's disease patients Scand J Gastroenterol 1995 30 699 706
19. Sanborn WJ Stenson WF Brynskov J Safety of celecoxib in patients with ulcerative colitis in remission: A randomised, double-blind, placebo-controlled study [abstract] Am J Gastroenterol. 2004 99 Suppl S257
20. Mahadevan U Loftus EV Jr. Teraine WJ et al Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease Am J Gastroenterol 2002 97 910 4
21. Singer II. Kaka DW Schloemann S et al Cyclooxygenase 2 is induced in colonic epithelium cells in inflammatory bowel disease Gastroenterology 1998 115 297 306
22. Hendel J Nielsen OH Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease Am J Gastroenterol 1997 92 1170 3
23. Su LK Kinzler KW Vogelstein B et al Multiple intestinal neoplasia caused by a mutation in the murine homology of the APC gene Science 1992 256 668 70
24. Mizuno H Sakamoto C Matsuda K Induction of cycloozygenase-2 in gastric lesions and its inhibition by the specific antagonist delays healing in mice Gastroenterology 1997 112 387 97
25. Shigeta J Takahashi S Okabe S Role of cyclooxygenase-2 in the healing of gastric ulcers in rats J Pharmacol Exp Ther 1998 286 1383 90
26. Reuter BK Asfaha S Buret A Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2 J Clin Invest 1996 98 2076 85
27. Karmeli F Cohen P Rachmilewitz D Cyclo-oxygenase-2 inhibitors ameliorate the severity of experimental colitis in rats Eur J Gasteroenterol Hepatol 2000 12 223 31
28. Chan FK Hung LC Suen BY et al Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis N Engl J Med 2002 347 26 2104 10
29. Laine L Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs - Nice or necessary¿ Rev Gastroenterol Disord 2004 4 Suppl 4 S33 S41